Aberle H et al (1997) β-catenin is a target for the ubiquitin–proteasome pathway. The EMBO Journal 16(13):3797–3804
Article CAS PubMed PubMed Central Google Scholar
Abrishamdar M, Jalali MS, Rashno M (2022) MALAT1 lncRNA and Parkinson’s disease: the role in the pathophysiology and significance for diagnostic and therapeutic approaches. Mol Neurobiol 59(9):5253–5262
Article CAS PubMed Google Scholar
Abuznait AH et al (2013) Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies. ACS Chem Neurosci 4(6):973–982
Article CAS PubMed PubMed Central Google Scholar
Adams J (2004) The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5(5):417–421
Article CAS PubMed Google Scholar
Adams J et al (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59(11):2615–2622
Aghaizu ND, Jin H, Whiting PJ (2020) Dysregulated wnt signalling in the Alzheimer’s brain. Brain Sci. https://doi.org/10.3390/brainsci10120902
Article PubMed PubMed Central Google Scholar
Ahmad AS et al (2005) Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 81(4):805–813
Article CAS PubMed Google Scholar
Akhtar A, Sah SP (2020) Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer’s disease. Neurochem Int 135:104707
Article CAS PubMed Google Scholar
AlAbdi L et al (2023) Loss-of-function variants in MYCBP2 cause neurobehavioural phenotypes and corpus callosum defects. Brain 146(4):1373–1387
Al-Awadhi FH et al (2020) Largazole is a brain-penetrant class I HDAC inhibitor with extended applicability to glioblastoma and CNS diseases. ACS Chem Neurosci 11(13):1937–1943
Article CAS PubMed Google Scholar
Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 89(1):121–145
Article CAS PubMed Google Scholar
Aldewachi H et al (2021) High-throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases. Bioengineering. https://doi.org/10.3390/bioengineering8020030
Article PubMed PubMed Central Google Scholar
Aman Y et al (2021) Autophagy in healthy aging and disease. Nat Aging 1(8):634–650
Article PubMed PubMed Central Google Scholar
Amini A, Esmaeili F, Golpich M (2024) Possible role of lncRNAs in amelioration of Parkinson’s disease symptoms by transplantation of dopaminergic cells. NPJ Parkinsons Dis 10(1):56
Article CAS PubMed PubMed Central Google Scholar
Anderson HJ et al (1997) Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemother Pharmacol 39(3):223–226
Article CAS PubMed Google Scholar
Anderson DJ et al (2015) Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 28(5):653–665
Article CAS PubMed PubMed Central Google Scholar
Ansari MA et al (2009) Protective effect of quercetin in primary neurons against Abeta(1–42): relevance to Alzheimer’s disease. J Nutr Biochem 20(4):269–275
Article CAS PubMed Google Scholar
Arkinson C et al (2025) Mechanisms and regulation of substrate degradation by the 26S proteasome. Nat Rev Mol Cell Biol 26(2):104–122
Article CAS PubMed Google Scholar
Arulvasub, C. and A.K. Rahiman, (n.d.) Magneto-structural correlation, antioxidant, DNA interaction and growth inhibition activities of new chloro-bridged phenolate complexes
Athanasopoulou S et al (2018) Beneficial effects of elderly tailored Mediterranean diet on the proteasomal proteolysis. Front Physiol 9:457
Article PubMed PubMed Central Google Scholar
Axelsson, V. (2006) Evaluation of neurotoxic properties of gliotoxin. Institutionen för neurokemi
Bagheri M et al (2011) Genistein ameliorates learning and memory deficits in amyloid beta(1–40) rat model of Alzheimer’s disease. Neurobiol Learn Mem 95(3):270–276
Article CAS PubMed Google Scholar
Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14(9):544–558
Article CAS PubMed PubMed Central Google Scholar
Barker N (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15(1):19–33
Article CAS PubMed Google Scholar
Barrangou R, Marraffini LA (2014) CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 54(2):234–244
Article CAS PubMed PubMed Central Google Scholar
Bartlett C et al (2011) BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest. J Cell Physiol 226(8):1989–1997
Article CAS PubMed PubMed Central Google Scholar
Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimers Dis 6(4):367–377
Article CAS PubMed Google Scholar
Baur JA et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444(7117):337–342
Article CAS PubMed PubMed Central Google Scholar
Bennett EJ et al (2007) Global changes to the ubiquitin system in Huntington’s disease. Nature 448(7154):704–708
Article CAS PubMed Google Scholar
Bhat KP et al (2014) Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc Natl Acad Sci USA 111(15):5706–5711
Article CAS PubMed PubMed Central Google Scholar
Bhat SA et al (2022) Ubiquitin proteasome system in immune regulation and therapeutics. Curr Opin Pharmacol 67:102310
Article CAS PubMed PubMed Central Google Scholar
Bhat MA et al (2025) The E3 ubiquitin ligase MARCH1 mediates downregulation of plasma membrane GABAB receptors under ischemic conditions by inhibiting fast receptor recycling. Sci Rep 15(1):1330
Article CAS PubMed PubMed Central Google Scholar
Bingol B, Sheng M (2016) Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Free Radic Biol Med 100:210–222
Comments (0)